Ataxia-telangiectasia Variant

Neurology·MeSH: Ataxia-Telangiectasia Variant

Prevalence

5.0 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Ataxia-telangiectasia Variant?

There are 1 clinical trial targeting Ataxia-telangiectasia Variant tracked by BioSniper.

What is the prevalence of Ataxia-telangiectasia Variant?

The estimated prevalence of Ataxia-telangiectasia Variant is approximately 5.0 per 100,000 population.

Deep-dive into Ataxia-telangiectasia Variant

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Ataxia-telangiectasia Variant — Drugs in Development & Clinical Trials | BioSniper